10 Under-the-Radar Stocks with Massive Upside for 2026
The benchmark 10-year Treasury yield hit its highest level since January 2025 that same week, while the 30-year yield briefly touched its highest since 2007, Reuters reported.
Alumis Inc. (ALMS)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Deep Track Capital David Kroin | 6,772,595 | $149,200,268 | 2.44% | |
| 2. | Samsara BioCapital Srini Akkaraju And Michael Dybbs | 6,345,219 | $139,785,175 | +11% | 13.58% |
| 3. | Cormorant Asset Management Bihua Chen | 3,949,241 | $87,001,779 | +9% | 4.37% |
| 4. | Saturn V Capital Management Xiaoying Tian | 3,202,075 | $70,541,712 | +3% | 12.77% |
| 5. | Octagon Capital Advisors Ting Jia | 2,830,700 | $62,360,321 | +12% | 6.9% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $17.00 | 588,235 | $9,999,995.00 | 1,853,488 | 2026-01-09 | Filing | |
| $17.00 | 294,117 | $4,999,989.00 | 2,908,332 | 2026-01-08 | Filing | |
| $17.00 | 117,647 | $1,999,999.00 | 5,702,536 | 2026-01-08 | Filing | |
| $17.00 | 294,117 | $4,999,989.00 | 2,908,332 | 2026-01-08 | Filing | |
| $17.00 | 117,647 | $1,999,999.00 | 5,702,536 | 2026-01-08 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 7,170,868 | $157,974,221 | 0% | |
| 2. | 5,896,995 | $129,910,800 | 47.94% | |
| 3. | 4,528,408 | $99,760,828 | 35.56% | |
| 4. | 4,247,670 | $93,576,170 | 20.33% | |
| 5. | 4,032,266 | $88,830,820 | 0% |
News See All
10 Best Performing Stocks of Q1 2026 to Watch for Q2
On April 3, Reuters reported that in the coming week, upcoming inflation data and initial company earnings could begin to show how the Middle East war is affecting the US economy and corporate America...
Chardan Highlights Alumis’s (ALMS) Potential After Envudeucitinib Hits All Phase 3 Endpoints in Psoriasis Trials
Alumis Inc. (NASDAQ:ALMS) is one of the new stocks on the rise.
10 New Stocks on the Rise
On January 21, Lynn Martin, NYSE president, joined CNBC's Sara Eisen to discuss the IPO landscape for 2026.
HC Wainwright & Co. Hikes Alumis Inc. (ALMS)'s Price Target To $40 From $20, Reiterates Buy Rating
Alumis Inc. (NASDAQ:ALMS) is among the 14 best booming stocks to buy right now. On January 9, HC Wainwright & Co.
14 Best Booming Stocks to Buy Right Now
In a report released on January 9, Goldman Sachs said that it expects the index to rally 12% in 2026.
11 Best New Penny Stocks to Buy Right Now
On July 28, the Opening Bid team at Yahoo Finance and Victoria Fernandez, chief market strategist at Crossmark Global Investments, discussed the rise in cheap stock trading and what it can mean for the...
Morgan Stanley Resumes Coverage of Alumis (ALMS) with $23 PT
On Monday, Morgan Stanley resumed its coverage of Alumis Inc.
Why Alumis (ALMS) Stock Is Advancing Today
Due to concerns about Alumis' cash reserves and competition, ALMS is changing hands for slightly above the value of its cash reserves, Oppenheimer analyst Jeff Jones reported.